Artificial Vital Organs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509241265

Publication Date:

September 19, 2024

Pages:

157

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Artificial organ is man-made machine or device that is used to replace the functions of missing or faulty organ and restores the functions of original organ.
The global market for Artificial Vital Organs was estimated to be worth US$ 26020 million in 2023 and is forecast to a readjusted size of US$ 47130 million by 2030 with a CAGR of 8.7% during the forecast period 2024-2030
Increasing organ failure and disability due to age-related disorders, new and modified technologies, increasing accidents and injuries leading to organ deletion, rise in number of people awaiting organ transplants and lack of donors are the major drivers responsible for the growth of this market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Vital Organs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Artificial Vital Organs by region & country, by Type, and by Application.
The Artificial Vital Organs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Vital Organs.
Market Segmentation
By Company
Edwards Lifesciences Corporation
Abbott Diabetes Care
Baxter International
Ekso Bionics
Asahi Kasei Medical
Jarvik Heart
Ottobock Healthcare
Abiomed Inc
Boston Scientific Corporation
Ossur
Medtronic
Zimmer Biomet
Heartware International, Inc
SynCardia Systems, LLC.
Iwalk, Inc.
Berlin Heart Gmbh
Biomet, Inc
CARMAT
Cleveland Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Fresenius Medical Care AG & Co. KGaA
Cyberonics, Inc
F. Hoffmann-La Roche Ltd
BiVACOR
Segment by Type:
Artificial Liver
Artificial Heart
Artificial Pancreas
Artificial Kidney
Artificial Lungs
Others
Segment by Application
Hospitals
Clinics
Research Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Artificial Vital Organs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Artificial Vital Organs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Artificial Vital Organs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Artificial Vital Organs Product Introduction
1.2 Global Artificial Vital Organs Market Size Forecast
1.3 Artificial Vital Organs Market Trends & Drivers
1.3.1 Artificial Vital Organs Industry Trends
1.3.2 Artificial Vital Organs Market Drivers & Opportunity
1.3.3 Artificial Vital Organs Market Challenges
1.3.4 Artificial Vital Organs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Vital Organs Players Revenue Ranking (2023)
2.2 Global Artificial Vital Organs Revenue by Company (2019-2024)
2.3 Key Companies Artificial Vital Organs Manufacturing Base Distribution and Headquarters
2.4 Key Companies Artificial Vital Organs Product Offered
2.5 Key Companies Time to Begin Mass Production of Artificial Vital Organs
2.6 Artificial Vital Organs Market Competitive Analysis
2.6.1 Artificial Vital Organs Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Artificial Vital Organs Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Vital Organs as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Artificial Liver
3.1.2 Artificial Heart
3.1.3 Artificial Pancreas
3.1.4 Artificial Kidney
3.1.5 Artificial Lungs
3.1.6 Others
3.2 Global Artificial Vital Organs Sales Value by Type
3.2.1 Global Artificial Vital Organs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Artificial Vital Organs Sales Value, by Type (2019-2030)
3.2.3 Global Artificial Vital Organs Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Research Centers
4.1.4 Others
4.2 Global Artificial Vital Organs Sales Value by Application
4.2.1 Global Artificial Vital Organs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Artificial Vital Organs Sales Value, by Application (2019-2030)
4.2.3 Global Artificial Vital Organs Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Artificial Vital Organs Sales Value by Region
5.1.1 Global Artificial Vital Organs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Artificial Vital Organs Sales Value by Region (2019-2024)
5.1.3 Global Artificial Vital Organs Sales Value by Region (2025-2030)
5.1.4 Global Artificial Vital Organs Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Artificial Vital Organs Sales Value, 2019-2030
5.2.2 North America Artificial Vital Organs Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Artificial Vital Organs Sales Value, 2019-2030
5.3.2 Europe Artificial Vital Organs Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Artificial Vital Organs Sales Value, 2019-2030
5.4.2 Asia Pacific Artificial Vital Organs Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Artificial Vital Organs Sales Value, 2019-2030
5.5.2 South America Artificial Vital Organs Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Artificial Vital Organs Sales Value, 2019-2030
5.6.2 Middle East & Africa Artificial Vital Organs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Vital Organs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Artificial Vital Organs Sales Value
6.3 United States
6.3.1 United States Artificial Vital Organs Sales Value, 2019-2030
6.3.2 United States Artificial Vital Organs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Artificial Vital Organs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Artificial Vital Organs Sales Value, 2019-2030
6.4.2 Europe Artificial Vital Organs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Artificial Vital Organs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Artificial Vital Organs Sales Value, 2019-2030
6.5.2 China Artificial Vital Organs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Artificial Vital Organs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Artificial Vital Organs Sales Value, 2019-2030
6.6.2 Japan Artificial Vital Organs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Artificial Vital Organs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Artificial Vital Organs Sales Value, 2019-2030
6.7.2 South Korea Artificial Vital Organs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Artificial Vital Organs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Vital Organs Sales Value, 2019-2030
6.8.2 Southeast Asia Artificial Vital Organs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Artificial Vital Organs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Artificial Vital Organs Sales Value, 2019-2030
6.9.2 India Artificial Vital Organs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Artificial Vital Organs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Edwards Lifesciences Corporation
7.1.1 Edwards Lifesciences Corporation Profile
7.1.2 Edwards Lifesciences Corporation Main Business
7.1.3 Edwards Lifesciences Corporation Artificial Vital Organs Products, Services and Solutions
7.1.4 Edwards Lifesciences Corporation Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.1.5 Edwards Lifesciences Corporation Recent Developments
7.2 Abbott Diabetes Care
7.2.1 Abbott Diabetes Care Profile
7.2.2 Abbott Diabetes Care Main Business
7.2.3 Abbott Diabetes Care Artificial Vital Organs Products, Services and Solutions
7.2.4 Abbott Diabetes Care Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Diabetes Care Recent Developments
7.3 Baxter International
7.3.1 Baxter International Profile
7.3.2 Baxter International Main Business
7.3.3 Baxter International Artificial Vital Organs Products, Services and Solutions
7.3.4 Baxter International Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.3.5 Ekso Bionics Recent Developments
7.4 Ekso Bionics
7.4.1 Ekso Bionics Profile
7.4.2 Ekso Bionics Main Business
7.4.3 Ekso Bionics Artificial Vital Organs Products, Services and Solutions
7.4.4 Ekso Bionics Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.4.5 Ekso Bionics Recent Developments
7.5 Asahi Kasei Medical
7.5.1 Asahi Kasei Medical Profile
7.5.2 Asahi Kasei Medical Main Business
7.5.3 Asahi Kasei Medical Artificial Vital Organs Products, Services and Solutions
7.5.4 Asahi Kasei Medical Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.5.5 Asahi Kasei Medical Recent Developments
7.6 Jarvik Heart
7.6.1 Jarvik Heart Profile
7.6.2 Jarvik Heart Main Business
7.6.3 Jarvik Heart Artificial Vital Organs Products, Services and Solutions
7.6.4 Jarvik Heart Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.6.5 Jarvik Heart Recent Developments
7.7 Ottobock Healthcare
7.7.1 Ottobock Healthcare Profile
7.7.2 Ottobock Healthcare Main Business
7.7.3 Ottobock Healthcare Artificial Vital Organs Products, Services and Solutions
7.7.4 Ottobock Healthcare Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.7.5 Ottobock Healthcare Recent Developments
7.8 Abiomed Inc
7.8.1 Abiomed Inc Profile
7.8.2 Abiomed Inc Main Business
7.8.3 Abiomed Inc Artificial Vital Organs Products, Services and Solutions
7.8.4 Abiomed Inc Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.8.5 Abiomed Inc Recent Developments
7.9 Boston Scientific Corporation
7.9.1 Boston Scientific Corporation Profile
7.9.2 Boston Scientific Corporation Main Business
7.9.3 Boston Scientific Corporation Artificial Vital Organs Products, Services and Solutions
7.9.4 Boston Scientific Corporation Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.9.5 Boston Scientific Corporation Recent Developments
7.10 Ossur
7.10.1 Ossur Profile
7.10.2 Ossur Main Business
7.10.3 Ossur Artificial Vital Organs Products, Services and Solutions
7.10.4 Ossur Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.10.5 Ossur Recent Developments
7.11 Medtronic
7.11.1 Medtronic Profile
7.11.2 Medtronic Main Business
7.11.3 Medtronic Artificial Vital Organs Products, Services and Solutions
7.11.4 Medtronic Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.11.5 Medtronic Recent Developments
7.12 Zimmer Biomet
7.12.1 Zimmer Biomet Profile
7.12.2 Zimmer Biomet Main Business
7.12.3 Zimmer Biomet Artificial Vital Organs Products, Services and Solutions
7.12.4 Zimmer Biomet Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.12.5 Zimmer Biomet Recent Developments
7.13 Heartware International, Inc
7.13.1 Heartware International, Inc Profile
7.13.2 Heartware International, Inc Main Business
7.13.3 Heartware International, Inc Artificial Vital Organs Products, Services and Solutions
7.13.4 Heartware International, Inc Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.13.5 Heartware International, Inc Recent Developments
7.14 SynCardia Systems, LLC.
7.14.1 SynCardia Systems, LLC. Profile
7.14.2 SynCardia Systems, LLC. Main Business
7.14.3 SynCardia Systems, LLC. Artificial Vital Organs Products, Services and Solutions
7.14.4 SynCardia Systems, LLC. Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.14.5 SynCardia Systems, LLC. Recent Developments
7.15 Iwalk, Inc.
7.15.1 Iwalk, Inc. Profile
7.15.2 Iwalk, Inc. Main Business
7.15.3 Iwalk, Inc. Artificial Vital Organs Products, Services and Solutions
7.15.4 Iwalk, Inc. Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.15.5 Iwalk, Inc. Recent Developments
7.16 Berlin Heart Gmbh
7.16.1 Berlin Heart Gmbh Profile
7.16.2 Berlin Heart Gmbh Main Business
7.16.3 Berlin Heart Gmbh Artificial Vital Organs Products, Services and Solutions
7.16.4 Berlin Heart Gmbh Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.16.5 Berlin Heart Gmbh Recent Developments
7.17 Biomet, Inc
7.17.1 Biomet, Inc Profile
7.17.2 Biomet, Inc Main Business
7.17.3 Biomet, Inc Artificial Vital Organs Products, Services and Solutions
7.17.4 Biomet, Inc Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.17.5 Biomet, Inc Recent Developments
7.18 CARMAT
7.18.1 CARMAT Profile
7.18.2 CARMAT Main Business
7.18.3 CARMAT Artificial Vital Organs Products, Services and Solutions
7.18.4 CARMAT Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.18.5 CARMAT Recent Developments
7.19 Cleveland Heart
7.19.1 Cleveland Heart Profile
7.19.2 Cleveland Heart Main Business
7.19.3 Cleveland Heart Artificial Vital Organs Products, Services and Solutions
7.19.4 Cleveland Heart Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.19.5 Cleveland Heart Recent Developments
7.20 MyLVAD
7.20.1 MyLVAD Profile
7.20.2 MyLVAD Main Business
7.20.3 MyLVAD Artificial Vital Organs Products, Services and Solutions
7.20.4 MyLVAD Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.20.5 MyLVAD Recent Developments
7.21 Cirtec Medical Systems
7.21.1 Cirtec Medical Systems Profile
7.21.2 Cirtec Medical Systems Main Business
7.21.3 Cirtec Medical Systems Artificial Vital Organs Products, Services and Solutions
7.21.4 Cirtec Medical Systems Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.21.5 Cirtec Medical Systems Recent Developments
7.22 Thoratec Corporation
7.22.1 Thoratec Corporation Profile
7.22.2 Thoratec Corporation Main Business
7.22.3 Thoratec Corporation Artificial Vital Organs Products, Services and Solutions
7.22.4 Thoratec Corporation Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.22.5 Thoratec Corporation Recent Developments
7.23 Fresenius Medical Care AG & Co. KGaA
7.23.1 Fresenius Medical Care AG & Co. KGaA Profile
7.23.2 Fresenius Medical Care AG & Co. KGaA Main Business
7.23.3 Fresenius Medical Care AG & Co. KGaA Artificial Vital Organs Products, Services and Solutions
7.23.4 Fresenius Medical Care AG & Co. KGaA Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.23.5 Fresenius Medical Care AG & Co. KGaA Recent Developments
7.24 Cyberonics, Inc
7.24.1 Cyberonics, Inc Profile
7.24.2 Cyberonics, Inc Main Business
7.24.3 Cyberonics, Inc Artificial Vital Organs Products, Services and Solutions
7.24.4 Cyberonics, Inc Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.24.5 Cyberonics, Inc Recent Developments
7.25 F. Hoffmann-La Roche Ltd
7.25.1 F. Hoffmann-La Roche Ltd Profile
7.25.2 F. Hoffmann-La Roche Ltd Main Business
7.25.3 F. Hoffmann-La Roche Ltd Artificial Vital Organs Products, Services and Solutions
7.25.4 F. Hoffmann-La Roche Ltd Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.25.5 F. Hoffmann-La Roche Ltd Recent Developments
7.26 BiVACOR
7.26.1 BiVACOR Profile
7.26.2 BiVACOR Main Business
7.26.3 BiVACOR Artificial Vital Organs Products, Services and Solutions
7.26.4 BiVACOR Artificial Vital Organs Revenue (US$ Million) & (2019-2024)
7.26.5 BiVACOR Recent Developments
8 Industry Chain Analysis
8.1 Artificial Vital Organs Industrial Chain
8.2 Artificial Vital Organs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Artificial Vital Organs Sales Model
8.5.2 Sales Channel
8.5.3 Artificial Vital Organs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Edwards Lifesciences Corporation
Abbott Diabetes Care
Baxter International
Ekso Bionics
Asahi Kasei Medical
Jarvik Heart
Ottobock Healthcare
Abiomed Inc
Boston Scientific Corporation
Ossur
Medtronic
Zimmer Biomet
Heartware International, Inc
SynCardia Systems, LLC.
Iwalk, Inc.
Berlin Heart Gmbh
Biomet, Inc
CARMAT
Cleveland Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Fresenius Medical Care AG & Co. KGaA
Cyberonics, Inc
F. Hoffmann-La Roche Ltd
BiVACOR

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂